We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies.
- Authors
Gómez-Pinedo, Ulises; Matías-Guiu, Jordi A.; Ojeda-Hernandez, Denise; de la Fuente-Martin, Sarah; Kamal, Ola Mohamed-Fathy; Benito-Martin, Maria Soledad; Selma-Calvo, Belen; Montero-Escribano, Paloma; Matías-Guiu, Jorge
- Abstract
The implantation of oligodendrocyte precursor cells may be a useful therapeutic strategy for targeting remyelination. However, it is yet to be established how these cells behave after implantation and whether they retain the capacity to proliferate or differentiate into myelin-forming oligodendrocytes. One essential issue is the creation of administration protocols and determining which factors need to be well established. There is controversy around whether these cells may be implanted simultaneously with corticosteroid treatment, which is widely used in many clinical situations. This study assesses the influence of corticosteroids on the capacity for proliferation and differentiation and the survival of human oligodendroglioma cells. Our findings show that corticosteroids reduce the capacity of these cells to proliferate and to differentiate into oligodendrocytes and decrease cell survival. Thus, their effect does not favour remyelination; this is consistent with the results of studies with rodent cells. In conclusion, protocols for the administration of oligodendrocyte lineage cells with the aim of repopulating oligodendroglial niches or repairing demyelinated axons should not include corticosteroids, given the evidence that the effects of these drugs may undermine the objectives of cell transplantation.
- Subjects
CELLULAR therapy; OLIGODENDROGLIA; METHYLPREDNISOLONE; CELL transplantation; CELL survival
- Publication
Cells (2073-4409), 2023, Vol 12, Issue 11, p1515
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells12111515